Extended adjuvant endocrine therapy in hormone dependent breast cancer: The paradigm of the NCIC-CTG MA.17/BIG 1–97 trial
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference61 articles.
1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Early Breast Cancer Trialists’ Collaborative Group (EBCTCG);Lancet,2005
2. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials;Early Breast Cancer Trialists’ Collaborative Group (EBCTCG);Lancet,2011
3. Metastatic behavior of breast cancer subtypes;Kennecke;Journal of Clinical Oncology,2010
4. Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen;Kennecke;Annals of Oncology,2007
5. Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial;Fisher;Journal of the National Cancer Institute,2001
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Melatonin as an Oncostatic Molecule Based on Its Anti-Aromatase Role in Breast Cancer;International Journal of Molecular Sciences;2021-01-04
2. Notch Signaling in Breast Cancer: A Role in Drug Resistance;Cells;2020-09-29
3. Efficacy and toxicity of extended aromatase inhibitors after adjuvant aromatase inhibitors-containing therapy for hormone-receptor-positive breast cancer: a literature-based meta-analysis of randomized trials;Breast Cancer Research and Treatment;2019-10-12
4. Extended duration of adjuvant aromatase inhibitor in breast cancer: a meta-analysis of randomized controlled trials;Gland Surgery;2018-10
5. A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial;Breast Cancer Research and Treatment;2018-05-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3